Phase 1 Attention Deficit Hyperactivity Disorder (ADHD) Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Cannabigerol Oil for Adolescents With ADHD (CAN-ADHD)

Attention Deficit Hyperactivity Disorder (ADHD)

Universidade do Sul de Santa Catarina60 enrolled1 locationNCT07592390

Recruiting

Phase 1

Methylphenidate to Address Attention and Executive Deficits Among Children With Sickle Cell Disease

Cognitive ImpairmentSickle Cell DiseaseAttention Deficit Hyperactivity Disorder (ADHD)+1 more

St. Jude Children's Research Hospital72 enrolled1 locationNCT07226219

Completed

Phase 1

Evaluation of the Pharmacokinetics of IPX233 Formulations in Healthy Volunteers

Attention Deficit Hyperactivity Disorder (ADHD)

Impax Pharmaceuticals,A Division of Impax Laboratories, Inc.20 enrolled1 locationACTRN12613001073796